Aurora Optoelectronics Co Ltd

SHG:600666 China Drug Manufacturers - General
Market Cap
$1.56 Billion
CN¥11.45 Billion CNY
Market Cap Rank
#7181 Global
#1196 in China
Share Price
CN¥4.16
Change (1 day)
-5.67%
52-Week Range
CN¥2.40 - CN¥4.41
All Time High
CN¥30.46
Categories
Companies in China Drug Manufacturers - General
About

Aurora Optoelectronics Co.,Ltd. engages in the production and sale of sapphire crystal materials in China. The company offers Sapphire crystal rod, wafer, substrate, window, and single crystal furnace, as well as LED Filament used for LED lighting and display, and consumer electronics window. It also provides computing power services; investment management; scientific research and technical servi… Read more

Aurora Optoelectronics Co Ltd (600666) - Net Assets

Latest net assets as of September 2025: CN¥1.14 Billion CNY

Based on the latest financial reports, Aurora Optoelectronics Co Ltd (600666) has net assets worth CN¥1.14 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.60 Billion) and total liabilities (CN¥467.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥1.14 Billion
% of Total Assets 70.9%
Annual Growth Rate 6.46%
5-Year Change 976.43%
10-Year Change -59.94%
Growth Volatility 122.37

Aurora Optoelectronics Co Ltd - Net Assets Trend (1993–2024)

This chart illustrates how Aurora Optoelectronics Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Aurora Optoelectronics Co Ltd (1993–2024)

The table below shows the annual net assets of Aurora Optoelectronics Co Ltd from 1993 to 2024.

Year Net Assets Change
2024-12-31 CN¥850.01 Million -20.86%
2023-12-31 CN¥1.07 Billion -38.86%
2022-12-31 CN¥1.76 Billion +706.98%
2021-12-31 CN¥-289.43 Million -466.52%
2020-12-31 CN¥78.97 Million -89.65%
2019-12-31 CN¥763.31 Million +9.79%
2018-12-31 CN¥695.21 Million -71.48%
2017-12-31 CN¥2.44 Billion -0.78%
2016-12-31 CN¥2.46 Billion +15.77%
2015-12-31 CN¥2.12 Billion +433.76%
2014-12-31 CN¥397.57 Million -7.10%
2013-12-31 CN¥427.95 Million -0.93%
2012-12-31 CN¥431.95 Million +8.98%
2011-12-31 CN¥396.37 Million -11.87%
2010-12-31 CN¥449.77 Million +9.81%
2009-12-31 CN¥409.61 Million +12.27%
2008-12-31 CN¥364.84 Million +7.88%
2007-12-31 CN¥338.20 Million +7.33%
2006-12-31 CN¥315.11 Million -0.40%
2005-12-31 CN¥316.36 Million +8.36%
2004-12-31 CN¥291.96 Million +7.68%
2003-12-31 CN¥271.12 Million +8.80%
2002-12-31 CN¥249.19 Million +3.94%
2001-12-31 CN¥239.73 Million -4.01%
2000-12-31 CN¥249.76 Million +8.15%
1999-12-31 CN¥230.95 Million -15.37%
1998-12-31 CN¥272.89 Million +22.02%
1997-12-31 CN¥223.64 Million +52.02%
1996-12-31 CN¥147.12 Million +9.76%
1995-12-31 CN¥134.03 Million --
1994-12-31 CN¥0.00 --
1993-12-31 CN¥121.93 Million --

Equity Component Analysis

This analysis shows how different components contribute to Aurora Optoelectronics Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 15626.6% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock CN¥2.29 Billion 273.45%
Other Components CN¥1.38 Billion 164.94%
Total Equity CN¥838.95 Million 100.00%

Aurora Optoelectronics Co Ltd Competitors by Market Cap

The table below lists competitors of Aurora Optoelectronics Co Ltd ranked by their market capitalization.

Company Market Cap
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
 		$1.03 Billion
Avino Silver & Gold Mines Ltd
NYSE MKT:ASM
 		$1.03 Billion
Cultural Investment Holdings Co Ltd
SHG:600715
 		$1.03 Billion
LINTEC CORP.
F:57T
 		$1.03 Billion
Iovance Biotherapeutics Inc
NASDAQ:IOVA
 		$1.03 Billion
Anhui Xinlong Electrical Co Ltd
SHE:002298
 		$1.03 Billion
Tompkins Financial Corporation
NYSE MKT:TMP
 		$1.03 Billion
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
 		$1.03 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Aurora Optoelectronics Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,060,393,359 to 838,945,173, a change of -221,448,186 (-20.9%).
  • Net loss of 171,418,215 reduced equity.
  • Dividend payments of 466,500 reduced retained earnings.
  • Share repurchases of 50,029,969 reduced equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥-171.42 Million -20.43%
Dividends Paid CN¥466.50K -0.06%
Share Repurchases CN¥50.03 Million -5.96%
Other Changes CN¥466.50K +0.06%
Total Change CN¥- -20.88%

Book Value vs Market Value Analysis

This analysis compares Aurora Optoelectronics Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 13.64x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 16.45x to 13.64x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1993-12-31 CN¥0.25 CN¥4.16 x
1994-12-31 CN¥0.29 CN¥4.16 x
1995-12-31 CN¥0.28 CN¥4.16 x
1996-12-31 CN¥0.31 CN¥4.16 x
1997-12-31 CN¥0.47 CN¥4.16 x
1998-12-31 CN¥0.53 CN¥4.16 x
1999-12-31 CN¥0.48 CN¥4.16 x
2000-12-31 CN¥0.52 CN¥4.16 x
2001-12-31 CN¥0.50 CN¥4.16 x
2002-12-31 CN¥0.52 CN¥4.16 x
2003-12-31 CN¥0.56 CN¥4.16 x
2004-12-31 CN¥0.59 CN¥4.16 x
2005-12-31 CN¥0.62 CN¥4.16 x
2006-12-31 CN¥0.66 CN¥4.16 x
2007-12-31 CN¥0.71 CN¥4.16 x
2008-12-31 CN¥0.74 CN¥4.16 x
2009-12-31 CN¥0.85 CN¥4.16 x
2010-12-31 CN¥0.98 CN¥4.16 x
2011-12-31 CN¥0.83 CN¥4.16 x
2012-12-31 CN¥0.93 CN¥4.16 x
2013-12-31 CN¥0.90 CN¥4.16 x
2014-12-31 CN¥0.55 CN¥4.16 x
2015-12-31 CN¥2.20 CN¥4.16 x
2016-12-31 CN¥3.20 CN¥4.16 x
2017-12-31 CN¥3.01 CN¥4.16 x
2018-12-31 CN¥0.56 CN¥4.16 x
2019-12-31 CN¥0.60 CN¥4.16 x
2020-12-31 CN¥0.05 CN¥4.16 x
2021-12-31 CN¥-0.25 CN¥4.16 x
2022-12-31 CN¥1.41 CN¥4.16 x
2023-12-31 CN¥0.38 CN¥4.16 x
2024-12-31 CN¥0.30 CN¥4.16 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Aurora Optoelectronics Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -20.43%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -46.84%
  • • Asset Turnover: 0.20x
  • • Equity Multiplier: 2.17x
  • Recent ROE (-20.43%) is above the historical average (-40.19%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1993 17.48% 10.68% 0.82x 1.99x CN¥9.08 Million
1994 13.87% 12.60% 0.60x 1.84x CN¥5.46 Million
1995 10.03% 7.84% 0.63x 2.02x CN¥36.34K
1996 3.73% 2.59% 0.78x 1.85x CN¥-9.22 Million
1997 14.42% 13.69% 0.71x 1.48x CN¥9.89 Million
1998 7.54% 6.92% 0.69x 1.59x CN¥-6.29 Million
1999 7.67% 6.17% 0.80x 1.56x CN¥-5.36 Million
2000 6.26% 5.30% 0.72x 1.64x CN¥-9.30 Million
2001 8.15% 6.38% 0.85x 1.50x CN¥-4.41 Million
2002 7.58% 5.68% 0.73x 1.82x CN¥-6.00 Million
2003 7.98% 6.39% 0.71x 1.75x CN¥-5.45 Million
2004 5.04% 3.51% 0.56x 2.58x CN¥-14.13 Million
2005 2.49% 1.65% 0.55x 2.74x CN¥-22.49 Million
2006 3.88% 2.56% 0.54x 2.80x CN¥-18.30 Million
2007 11.12% 7.11% 0.57x 2.73x CN¥3.60 Million
2008 10.64% 6.04% 0.60x 2.95x CN¥2.24 Million
2009 10.32% 5.70% 0.59x 3.09x CN¥1.25 Million
2010 9.57% 4.89% 0.65x 3.02x CN¥-1.86 Million
2011 9.00% 3.66% 0.62x 3.96x CN¥-3.96 Million
2012 8.39% 3.02% 0.80x 3.49x CN¥-6.99 Million
2013 7.63% 2.47% 0.67x 4.62x CN¥-10.15 Million
2014 33.17% 21.26% 0.30x 5.16x CN¥92.00 Million
2015 14.21% 26.12% 0.20x 2.76x CN¥89.13 Million
2016 19.07% 31.47% 0.22x 2.79x CN¥221.31 Million
2017 -1.00% -2.03% 0.16x 2.97x CN¥-265.67 Million
2018 -258.11% -155.52% 0.26x 6.45x CN¥-1.81 Billion
2019 9.05% 9.20% 0.20x 4.97x CN¥-7.04 Million
2020 -1204.60% -131.83% 0.18x 51.92x CN¥-690.60 Million
2021 0.00% -69.05% 0.27x 0.00x CN¥-451.99 Million
2022 3.49% 11.39% 0.15x 1.99x CN¥-113.07 Million
2023 -63.68% -205.93% 0.15x 2.05x CN¥-781.32 Million
2024 -20.43% -46.84% 0.20x 2.17x CN¥-255.31 Million

Industry Comparison

This section compares Aurora Optoelectronics Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - General industry.

Industry Context

  • Industry: Drug Manufacturers - General
  • Average net assets among peers: $1,443,093,618
  • Average return on equity (ROE) among peers: -7.88%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Aurora Optoelectronics Co Ltd (600666) CN¥1.14 Billion 17.48% 0.41x $1.03 Billion
Zhejiang Int'L Group Co Ltd (000411) $177.19 Million 13.55% 0.63x $201.14 Million
Zhejiang Zhenyuan Share Co Ltd (000705) $280.61 Million 7.70% 0.99x $310.45 Million
Hunan Jingfeng Pharmaceutical (000908) $638.18 Million -181.03% 3.22x $202.85 Million
Hubei Guangji Pharmaceutical Co Ltd (000952) $477.68 Million 3.28% 0.64x $234.89 Million
Zhejiang Haisen Pharmaceutical Co. Ltd. A (001367) $361.29 Million 26.02% 0.32x $146.91 Million
Yifan Xinfu Pharmaceutical Co Ltd (002019) $9.15 Billion 2.09% 0.37x $1.03 Billion
Guangdong Jiaying Pharmaceutical Co Ltd (002198) $278.08 Million 2.72% 0.13x $459.10 Million
Chongqing Lummy Pharmaceutical (300006) $107.91 Million 22.70% 0.99x $476.38 Million
Zhejiang Jolly Pharmaceutical Co Ltd (300181) $1.44 Billion 5.91% 0.29x $1.19 Billion
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) $1.53 Billion 18.22% 0.05x $893.48 Million